D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 94 Citations 35,398 363 World Ranking 4914 National Ranking 2769

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Psychiatry

Daniel Weintraub spends much of his time researching Psychiatry, Parkinson's disease, Disease, Internal medicine and Dementia. His Psychiatry research includes elements of Clinical psychology and Punding. His studies in Parkinson's disease integrate themes in fields like Apathy, Severity of illness, Central nervous system disease and Cohort study.

He combines subjects such as Psychological intervention, Epidemiology and Intensive care medicine with his study of Disease. The concepts of his Internal medicine study are interwoven with issues in Geriatric Depression Scale, Placebo and Effects of sleep deprivation on cognitive performance. His Dementia study integrates concerns from other disciplines, such as Biomarker, Alzheimer's disease, Cognition and Oncology.

His most cited work include:

  • Diagnostic Criteria for Mild Cognitive Impairment in Parkinson’s Disease: Movement Disorder Society Task Force Guidelines (1267 citations)
  • Impulse Control Disorders in Parkinson Disease: A Cross-Sectional Study of 3090 Patients (993 citations)
  • Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. (897 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Parkinson's disease, Psychiatry, Disease, Internal medicine and Dementia. His studies deal with areas such as Rating scale, Clinical psychology, Biomarker, Physical therapy and Movement disorders as well as Parkinson's disease. His Psychiatry course of study focuses on Impulse control disorder and Punding and Dopamine dysregulation syndrome.

His Disease research is multidisciplinary, relying on both Psychological intervention, Neurology and Clinical trial. His research in Internal medicine tackles topics such as Placebo which are related to areas like Randomized controlled trial and Citalopram. His work deals with themes such as Alzheimer's disease and Cognition, Effects of sleep deprivation on cognitive performance, which intersect with Dementia.

He most often published in these fields:

  • Parkinson's disease (67.47%)
  • Psychiatry (52.41%)
  • Disease (52.61%)

What were the highlights of his more recent work (between 2019-2021)?

  • Parkinson's disease (67.47%)
  • Disease (52.61%)
  • Internal medicine (43.37%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Parkinson's disease, Disease, Internal medicine, Cognition and Dementia. His research integrates issues of Physical medicine and rehabilitation, Rating scale, Anxiety, Movement disorders and Depression in his study of Parkinson's disease. The study incorporates disciplines such as Psychiatry, Psychosis, Biomarker, Pediatrics and Cohort in addition to Disease.

His Internal medicine study incorporates themes from Gastroenterology and Oncology. His Cognition research includes themes of Cognitive psychology, Behavioral neurology and Cognitive decline. Daniel Weintraub has researched Dementia in several fields, including Neuropsychology, Gerontology and Audiology.

Between 2019 and 2021, his most popular works were:

  • New evidence on the management of Lewy body dementia. (32 citations)
  • New evidence on the management of Lewy body dementia. (32 citations)
  • Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study (18 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Psychiatry

Daniel Weintraub focuses on Parkinson's disease, Disease, Internal medicine, Dementia and Cognition. The various areas that Daniel Weintraub examines in his Parkinson's disease study include Scale, Movement disorders, Physical medicine and rehabilitation and Audiology. His study on Disease also encompasses disciplines like

  • Biomarker which is related to area like Cerebrospinal fluid,
  • Psychiatry that connect with fields like Neuropsychiatric inventory.

His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Oncology. His Dementia study combines topics in areas such as Cognitive diagnosis and Disease management. He has included themes like Observational study, Anticholinergic, Hypnotic, Antidepressant and Pediatrics in his Cognition study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Diagnostic Criteria for Mild Cognitive Impairment in Parkinson’s Disease: Movement Disorder Society Task Force Guidelines

Irene Litvan;Jennifer G. Goldman;Alexander I. Tröster;Ben A. Schmand.
Movement Disorders (2012)

1774 Citations

Impulse Control Disorders in Parkinson Disease: A Cross-Sectional Study of 3090 Patients

Daniel Weintraub;Juergen Koester;Marc N. Potenza;Andrew D. Siderowf.
JAMA Neurology (2010)

1377 Citations

Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

Lon S. Schneider;Pierre N. Tariot;Karen S. Dagerman;Sonia M. Davis.
The New England Journal of Medicine (2006)

1272 Citations

Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease

S. Hoops;S. Nazem;A. D. Siderowf;J. E. Duda.
Neurology (2009)

933 Citations

Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

D. Aarsland;K. Bronnick;C. Williams-Gray;D. Weintraub.
Neurology (2010)

807 Citations

Association of dopamine agonist use with impulse control disorders in Parkinson disease.

Daniel Weintraub;Andrew D. Siderowf;Marc N. Potenza;Joseph Goveas.
JAMA Neurology (2006)

750 Citations

MDS Task Force on Mild Cognitive Impairment in Parkinson’s disease: Critical Review of PD-MCI

Irene Litvan;Dag Aarsland;Charles H. Adler;Jennifer G. Goldman.
Movement Disorders (2011)

722 Citations

Depression Rating Scales in Parkinson’s Disease: Critique and Recommendations

Anette Schrag;Paolo Barone;Richard G. Brown;Albert F.G. Leentjens.
Movement Disorders (2007)

668 Citations

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

Paolo Barone;Werner Poewe;Stefan Albrecht;Catherine Debieuvre.
Lancet Neurology (2010)

542 Citations

Effect of Psychiatric and Other Nonmotor Symptoms on Disability in Parkinson's Disease

Daniel Weintraub;Paul J. Moberg;John E. Duda;Ira R. Katz.
Journal of the American Geriatrics Society (2004)

468 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Daniel Weintraub

Dag Aarsland

Dag Aarsland

King's College London

Publications: 201

Daniela Berg

Daniela Berg

Kiel University

Publications: 97

Kaj Blennow

Kaj Blennow

University of Gothenburg

Publications: 95

K. Ray Chaudhuri

K. Ray Chaudhuri

King's College London

Publications: 95

Clive Ballard

Clive Ballard

University of Exeter

Publications: 92

Pablo Martinez-Martin

Pablo Martinez-Martin

Instituto de Salud Carlos III

Publications: 91

Paolo Barone

Paolo Barone

University of Salerno

Publications: 88

Angelo Antonini

Angelo Antonini

University of Padua

Publications: 87

Henrik Zetterberg

Henrik Zetterberg

University of Gothenburg

Publications: 86

David J. Burn

David J. Burn

Newcastle University

Publications: 81

Anthony E. Lang

Anthony E. Lang

University of Toronto

Publications: 77

Paul Krack

Paul Krack

University of Bern

Publications: 72

Michael S. Okun

Michael S. Okun

University of Florida

Publications: 64

John Q. Trojanowski

John Q. Trojanowski

University of Pennsylvania

Publications: 63

Roger A. Barker

Roger A. Barker

University of Cambridge

Publications: 62

Werner Poewe

Werner Poewe

Innsbruck Medical University

Publications: 61

Something went wrong. Please try again later.